Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $483,203 - $898,126
-3,821 Closed
0 $0
Q4 2021

Jan 27, 2022

SELL
$225.82 - $368.51 $406,927 - $664,055
-1,802 Reduced 32.05%
3,821 $970,000
Q3 2021

Oct 15, 2021

SELL
$221.9 - $484.47 $281,147 - $613,823
-1,267 Reduced 18.39%
5,623 $2.16 Million
Q2 2021

Jul 22, 2021

SELL
$129.91 - $234.98 $269,563 - $487,583
-2,075 Reduced 23.15%
6,890 $1.62 Million
Q1 2021

May 07, 2021

SELL
$109.18 - $185.98 $124,792 - $212,575
-1,143 Reduced 11.31%
8,965 $1.17 Million
Q4 2020

Jan 19, 2021

BUY
$65.74 - $169.86 $664,499 - $1.72 Million
10,108 New
10,108 $1.06 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Meridian Wealth Management, LLC Portfolio

Follow Meridian Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Management, LLC with notifications on news.